Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

Recent Updates in Upper Gl Cancers

Integrity CE

S. Mukherjee

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

Clinical Applications of ctDNA in Breast Cancer Diagnosis and Manage…

University of Miami Sylvester Comprehensive Cancer Center

D. Tripathy

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancers Inc…

2024 ASCO® Annual Meeting Insights Hub

N. Uboha, A. Turk, K. Spencer, M. Cecchini

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

ASCO GI 2023 Conference Coverage

N. Uboha, A. Turk, K. Spencer, M. Cecchini

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

Year in Review: Upper GI Cancers

Moffitt Cancer Center

R. Kim, R. Mehta

ASCO GI 2023 Key Studies

ASCO GI 2023 Conference Coverage

R. Kim, R. Mehta

NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing

Total Health

S. Kazmi

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials Includ…

Insights from 2023 ASCO® Annual Meeting

Y. Janjigian, S. Cytryn, S. Maron

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

Visible vs. Invisible Cancers - The Genomics and Natural History

Laurence Klotz

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

ASCO® GI 2024 Summary: "Gastro-Esophageal Key Studies Including KEYN…

Insights from 2024 ASCO® GI Annual Meeting

R. Kim, R. Mehta

Opus One: Final Results - RFA in Axial Skeleton

Jason Levy